{Reference Type}: Case Reports
{Title}: Nakaseomyces glabrata endocarditis: A therapeutic dilemma.
{Author}: Jim KK;Daems JJN;Boekholdt SM;van Dijk K;
{Journal}: Med Mycol Case Rep
{Volume}: 40
{Issue}: 0
{Year}: 2023 Jun
暂无{DOI}: 10.1016/j.mmcr.2023.04.002
{Abstract}: Candida infective endocarditis is a rare but serious entity that often requires aggressive treatment. However, treatment can be challenging in patients infected with drug-resistant fungi and/or with substantial comorbidity. Moreover, recommendations in treatment guidelines for these patients are based on limited clinical data due to their rarity. Here we report a case of Nakaseomyces glabrata (Candida glabrata) prosthetic valve endocarditis in a patient with congenital heart disease. This case illustrates a therapeutic dilemma for Nakaseomyces glabrata prosthetic valve endocarditis and the need for novel antifungal drugs and further clinical studies.